C-reactive protein 3′ UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 406-411

  Vormittag, R ^a   Funk, M ^a   Mannhalter, C ^a   Schonauer V ^a   Vukovich, T ^a   Minar, E ^a   Bialonczyk, C ^b   Hirschl, M ^c   Pabinger, I ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Wilhelminenspital Vienna ^*  (Austria)

^c HANUSCH HOSPITAL   (Austria)

Author keywords

C reactive protein; C reactive protein 3 UTR (+1444) C>T polymorphism; Pulmonary embolism; Venous thrombosis

Indexed keywords

C REACTIVE PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; VENOUS THROMBOEMBOLISM;

AUSTRIA; C-REACTIVE PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 33748036383     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.006     Document Type: Article

References (23)

1. Lowe G.D. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3 8 (2005) 1618-1627
2. Wilson P. Assessing coronary heart disease risk with traditional and novel risk factors. Clin Cardiol 27 6 Suppl. 3 (2004) III7-III11
3. Retterstol L., Eikvar L., and Berg K. A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169 2 (2003) 279-282
4. MacGregor A.J., Gallimore J.R., Spector T.D., and Pepys M.B. Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem 50 1 (2004) 130-134
5. Brull D.J., Serrano N., Zito F., et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23 11 (2003) 2063-2069
6. Tsai A.W., Cushman M., Rosamond W.D., et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113 8 (2002) 636-642
7. Kamphuisen P.W., Eikenboom J.C., Vos H.L., et al. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost 81 5 (1999) 680-683
8. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 14 (1997) 973-979
9. Vormittag R., Vukovich T., Schonauer V., et al. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism. Thromb Haemost 93 3 (2005) 488-493
10. Cermak J., Key N.S., Bach R.R., et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82 2 (1993) 513-520
11. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 18 (2000) 2165-2168
12. Devaraj S., Xu D.Y., and Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107 3 (2003) 398-404
13. Reitsma P.H., and Rosendaal F.R. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2 4 (2004) 619-622
14. Vukovich T.C., Mustafa S., Rumpold H., and Wagner O. Evaluation of a turbidimetric Denka Seiken C-reactive protein assay for cardiovascular risk estimation and conventional inflammation diagnosis. Clin Chem 49 3 (2003) 511-512
15. Pabinger I., Grafenhofer H., Kaider A., et al. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol 21 5 (2001) 874-879
16. Lozanski G., Jiang S.L., Samols D., and Kushner I. C-reactive protein and serum amyloid A mRNA stability following induction by cytokines. Cytokine 8 7 (1996) 534-540
17. D'Aiuto F., Casas J.P., Shah T., et al. C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179 2 (2005) 413-417
18. Zee R.Y., Hegener H.H., Cook N.R., and Ridker P.M. C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis. J Thromb Haemost 2 8 (2004) 1240-1243
19. Eklund C., Lehtimaki T., and Hurme M. Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet 32 4 (2005) 229-232
20. Chen J., Zhao J., Huang J., et al. 717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing Atherosclerosis Study. J Mol Med 83 1 (2005) 72-78
21. Kovacs A., Green F., Hansson L.O., et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178 1 (2005) 193-198
22. Zee R.Y., Hegener H.H., Fernandez-Cruz A., and Lindpaintner K. C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis. Atherosclerosis 176 2 (2004) 393-396
23. Zee R.Y., and Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162 1 (2002) 217-219